| Application no. and date | 12764765.9 (espacenet) (Federated) (European Patent Register), 20120330 | | Patent/reg. no. and date | DK/EP 2694072, 20171129 | | Publication date | 20140212 | | Priority no. and date | US 201161470624 P, 20110401, US 201161470803 P, 20110401 | | EP pub. no. and date |
EP 2694072 20140212 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco CA 94080-4990, US | | Applicant ref. no. | P237560DKEP | | Inventor | NANNINI, Michelle, 1 DNA Way
South San Francisco
California 94080-4990, US,
SAMPATH, Deepak, 1 DNA Way
South San Francisco
California 94080-4990, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61P 35/00 (2006.01) , C07D 239/70 (2006.01) | | Title | Kombination af AKT-inhibitor-forbindelse og abirateron til anvendelse i terapeutiske behandlinger | | Int. application no. | US2012031679 | | Int. publication no. | WO2012135759 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
